0.3002  -0.045 (-12.91%)		12-15 15:32
Open: 0.3344 High: 0.3373 Volume: 543,060		Pre. Close: 0.3447 Low: 0.2994 Market Cap: 3(M)

Short term
Mid term
Targets	6-month :	0.44	1-year :	0.5
Resists	First :	0.38	Second :	0.43
Pivot price	0.35
Supports	First :	0.3	Second :	0.25
MAs	MA(5) :	0.35	MA(20) :	0.34
	MA(100) :	0.7	MA(250) :	0
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	38.9	D(3) :	63.5
RSI	RSI(14): 33.3
52-week	High :	4.33	Low :	0.3

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AZTR ] has closed below the lower bollinger band by 2.9%. Bollinger Bands are 66.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.37 - 0.37	0.37 - 0.37
Low:	0.33 - 0.34	0.34 - 0.34
Close:	0.34 - 0.35	0.35 - 0.35

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

Mon, 24 Nov 2025
Azitra Inc Secures $1.5M in Private Placement - MSN

Mon, 24 Nov 2025
Azitra Inc Secures $1.5M in Private Placement - MSN

Mon, 24 Nov 2025
Azitra (NYSE: AZTR) Announces $1.5M Private Placement with Warrants at $0.32 - Stock Titan

Fri, 07 Nov 2025
Azitra (NYSE American: AZTR) says $44M registered direct offering report is false - Stock Titan

Fri, 07 Nov 2025
Azitra, Inc. Addresses False Report Regarding Sale of Securities - PR Newswire

Mon, 20 Oct 2025
Azitra Shares Soar Pre-Market: What’s Driving The Surge? - Stocktwits

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.